SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wade Sickler who wrote (72)7/9/1997 2:07:00 AM
From: kathleen   of 656
 
Wade and Howard,

There was probably a lot of profit-taking on the news.

There was a mention in the Yahoo news article that Bristol Myers might
be able to extend their U.S. patent on Taxol. Glaxo was sucessful with
extending Zantac's patent for several years. If Bristol Myers is
able to do this, Immunex would lose this potential market.
This is the only thing negative I detected in the news today.

Kathleen
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News